Sulfonamide derivative or a pharmaceutically acceptable acid addition salt thereof
2014
The present invention aims at providing a novel low-molecular compounds exhibiting orexin receptor agonistic activity are expected to be useful as a prophylactic or therapeutic agent such as narcolepsy. The present invention relates to compounds of the general formula (I) compound or a pharmaceutically acceptable acid addition salt represented by :( symbols are the same meaning as defined in the specification of formula) with orexin receptor agonist activity , and it provides the compound or orexin receptor agonist containing a pharmaceutically acceptable acid addition salts.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI